· Cards must be handwritten, legible, and on ruled index cards. · · The following information must be on the Drug Card for Each Drug: · Generic and Trade /Brand Names      ( American Ony ) · Classifications: · Therapeutic · Pharmacological · Indications/Uses · Contraindications · Adverse reactions by all            systems · Safe dosage range · 3 nursing implications · Action Propylthiouracil Methimazole Glucotrol Prandin Avandia Januvia Invokana Tiamiconolone Cymbalta Zyban

Drug Card – Example

Generic and Trade/Brand Names:

1. Propylthiouracil (PTU)
2. Methimazole (Tapazole)
3. Glucotrol (Glipizide)
4. Prandin (Repaglinide)
5. Avandia (Rosiglitazone)
6. Januvia (Sitagliptin)
7. Invokana (Canagliflozin)
8. Tiamiconolone (Kenalog)
9. Cymbalta (Duloxetine)
10. Zyban (Bupropion)

Classifications:

1. Propylthiouracil (PTU):
– Therapeutic Classification: Antithyroid agent
– Pharmacological Classification: Thioamide

2. Methimazole (Tapazole):
– Therapeutic Classification: Antithyroid agent
– Pharmacological Classification: Thioamide

3. Glucotrol (Glipizide):
– Therapeutic Classification: Antidiabetic agent (Sulfonylurea)
– Pharmacological Classification: Hypoglycemic agent (Insulin secretagogue)

4. Prandin (Repaglinide):
– Therapeutic Classification: Antidiabetic agent (Meglitinide)
– Pharmacological Classification: Hypoglycemic agent (Insulin secretagogue)

5. Avandia (Rosiglitazone):
– Therapeutic Classification: Antidiabetic agent (Thiazolidinedione)
– Pharmacological Classification: Antidiabetic agent (Peroxisome proliferator-activated receptor agonist)

6. Januvia (Sitagliptin):
– Therapeutic Classification: Antidiabetic agent (Dipeptidyl peptidase-4 inhibitor)
– Pharmacological Classification: Antidiabetic agent

7. Invokana (Canagliflozin):
– Therapeutic Classification: Antidiabetic agent (Sodium glucose co-transporter 2 inhibitor)
– Pharmacological Classification: Antidiabetic agent

8. Tiamiconolone (Kenalog):
– Therapeutic Classification: Topical corticosteroid (Intermediate potency)
– Pharmacological Classification: Glucocorticoid

9. Cymbalta (Duloxetine):
– Therapeutic Classification: Selective serotonin and norepinephrine reuptake inhibitor (SNRI) antidepressant
– Pharmacological Classification: Antidepressant

10. Zyban (Bupropion):
– Therapeutic Classification: Antidepressant (Smoking cessation aid)
– Pharmacological Classification: Aminoketone

Indications/Uses:

1. Propylthiouracil (PTU): Used for the treatment of hyperthyroidism, including Graves’ disease.

2. Methimazole (Tapazole): Used for the treatment of hyperthyroidism, including Graves’ disease.

3. Glucotrol (Glipizide): Used to control blood sugar levels in patients with type 2 diabetes.

4. Prandin (Repaglinide): Used to control blood sugar levels in patients with type 2 diabetes.

5. Avandia (Rosiglitazone): Used to control blood sugar levels in patients with type 2 diabetes.

6. Januvia (Sitagliptin): Used to control blood sugar levels in patients with type 2 diabetes.

7. Invokana (Canagliflozin): Used to control blood sugar levels in patients with type 2 diabetes.

8. Tiamiconolone (Kenalog): Used to treat various skin conditions, such as eczema and psoriasis.

9. Cymbalta (Duloxetine): Used to treat major depressive disorder, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain.

10. Zyban (Bupropion): Used as an aid in smoking cessation.

Contraindications:

1. Propylthiouracil (PTU):
– Hypersensitivity to PTU or any component of the formulation.
– Severe liver disease.

2. Methimazole (Tapazole):
– Hypersensitivity to methimazole or any component of the formulation.
– Severe liver disease.
– Pregnancy and lactation (avoid use during these times).

3. Glucotrol (Glipizide):
– Hypersensitivity to glipizide or any component of the formulation.
– Diabetic ketoacidosis.
– Type 1 diabetes.

4. Prandin (Repaglinide):
– Hypersensitivity to repaglinide or any component of the formulation.
– Diabetic ketoacidosis.
– Type 1 diabetes.

5. Avandia (Rosiglitazone):
– Hypersensitivity to rosiglitazone or any component of the formulation.
– History of heart failure or active heart disease.

6. Januvia (Sitagliptin):
– Hypersensitivity to sitagliptin or any component of the formulation.

7. Invokana (Canagliflozin):
– Hypersensitivity to canagliflozin or any component of the formulation.
– Severe renal impairment (eGFR less than 30 ml/min/1.73 m²).
– End-stage renal disease or on dialysis.
– Diabetic ketoacidosis.

8. Tiamiconolone (Kenalog):
– Hypersensitivity to tiamcinolone or any component of the formulation.
– Viral, fungal, or tuberculous skin infections.

9. Cymbalta (Duloxetine):
– Hypersensitivity to duloxetine or any component of the formulation.
– Use of monoamine oxidase inhibitors (MAOIs) within the past 14 days.
– Uncontrolled narrow-angle glaucoma.

10. Zyban (Bupropion):
– Hypersensitivity to bupropion or any component of the formulation.
– Seizure disorder.
– Current or previous diagnosis of anorexia nervosa or bulimia nervosa.
– Use of monoamine oxidase inhibitors (MAOIs) within the past 14 days.

Adverse Reactions by All Systems:

1. Propylthiouracil (PTU):
– Endocrine system: Hypothyroidism.
– Dermatological: Rash, pruritus.
– Gastrointestinal: Nausea, vomiting.

2. Methimazole (Tapazole):
– Endocrine system: Hypothyroidism.
– Dermatological: Rash, pruritus.
– Gastrointestinal: Nausea, vomiting.

3. Glucotrol (Glipizide):
– Gastrointestinal: Nausea, diarrhea, constipation.
– Hematologic: Hemolytic anemia, thrombocytopenia.

4. Prandin (Repaglinide):
– Gastrointestinal: Nausea, diarrhea, constipation.
– Hematologic: Hemolytic anemia, thrombocytopenia.

5. Avandia (Rosiglitazone):
– Gastrointestinal: Nausea, diarrhea, constipation.
– Cardiovascular: Edema, congestive heart failure.

6. Januvia (Sitagliptin):
– Gastrointestinal: Nausea, diarrhea, constipation.
– Dermatological: Rash, pruritus.

7. Invokana (Canagliflozin):
– Genitourinary: Urinary tract infections, genital mycotic infections.
– Gastrointestinal: Nausea, diarrhea.

8. Tiamiconolone (Kenalog):
– Dermatological: Rash, itching, burning, irritation, dryness.
– Local: Atrophy, striae, miliaria, pruritus.

9. Cymbalta (Duloxetine):
– Gastrointestinal: Nausea, dry mouth, constipation.
– Neurological: Dizziness, somnolence.

10. Zyban (Bupropion):
– Neurological: Headache, insomnia.
– Gastrointestinal: Dry mouth, nausea.

Safe Dosage Range: